Diana Z. Osmanova

CYP1A2 and CYP2D6 Gene Polymorphisms in Schizophrenic Patients with Neuroleptic Drug-Induced Side Effects

Svetlana А. Ivanova, Natalya M. Vyalova, Ivan V. Pozhidaev et al. · Bulletin of Experimental Biology and Medicine · 2016 · 36 citations

Medicine, Pharmacology, Psychiatry +16

Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia

Svetlana А. Ivanova, Diana Z. Osmanova, Maxim B. Freidin et al. · The World Journal of Biological Psychiatry · 2016 · 33 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Prolactin gene polymorphism (− 1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics

Svetlana А. Ivanova, Diana Z. Osmanova, Anastasiia S. Boiko et al. · Schizophrenia Research · 2016 · 28 citations · Full text

Life Sciences, Genetics, Psychiatry +13

A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia

Diana Z. Osmanova, Maxim B. Freidin, Olga Fedorenko et al. · BMC Medical Genetics · 2019 · 25 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of<i>CHRM1</i>and<i>CHRM2</i>muscarinic receptors

Anastasiia S. Boiko, Svetlana А. Ivanova, Ivan V. Pozhidaev et al. · The World Journal of Biological Psychiatry · 2019 · 22 citations · Full text

Medicine, Neuroscience, Psychiatry +17